Literature DB >> 7082020

Applications of glucocorticosteroids. The effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis.

A du Vivier, H Phillips, M Hehir.   

Abstract

To determine a schedule for continuous suppression of epidermal cell DNA synthesis, 0.05% fluocinonide ointment was applied either twice daily or once on alternate days to hairless mouse skin for 174 hours. Suppression occurred similarly for both regimens for 78 hours followed by an increase in DNA synthesis despite continued application of fluocinonide. The systemic effect was less marked with the alternate-day schedule. The effect of a single application of the fluocinonide ointment was also studied over 174 hours. Substantial inhibition of DNA synthesis occurred but for a shorter period followed by an increase and then return to normal values. Experiments were performed where second applications were made at various time intervals after the first. These did not appear to affect events until 192 hours had elapsed, when a second application caused profound inhibition of DNA synthesis once more.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082020     DOI: 10.1001/archderm.118.5.305

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  Krüppel-like factor 9 is a circadian transcription factor in human epidermis that controls proliferation of keratinocytes.

Authors:  Florian Spörl; Sandra Korge; Karsten Jürchott; Minetta Wunderskirchner; Katja Schellenberg; Sven Heins; Aljona Specht; Claudia Stoll; Roman Klemz; Bert Maier; Horst Wenck; Annika Schrader; Dieter Kunz; Thomas Blatt; Achim Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

2.  Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.

Authors:  Marianne Demerjian; Eung-Ho Choi; Mao-Qiang Man; Sandra Chang; Peter M Elias; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2009-02-19       Impact factor: 3.960

3.  Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes.

Authors:  Xiao-Yong Man; Wei Li; Jia-Qi Chen; Jiong Zhou; Lilla Landeck; Kai-Hong Zhang; Zhen Mu; Chun-Ming Li; Sui-Qing Cai; Min Zheng
Journal:  Cell Mol Life Sci       Date:  2013-01-19       Impact factor: 9.261

4.  Comparison of two therapeutic regimens using the same topical corticoid for stable psoriasis.

Authors:  T P Senter; D H Stimson; G Charles; R J Brand
Journal:  West J Med       Date:  1983-11

Review 5.  Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.

Authors:  Sean Yilong Tan; Nisha Suyien Chandran; Ellie Ci-En Choi
Journal:  Clin Drug Investig       Date:  2021-08-18       Impact factor: 2.859

6.  Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.

Authors:  Mari Kishibe; Gleb Baida; Pankaj Bhalla; Robert M Lavker; Bethanee Schlosser; Sin Iinuma; Shigetaka Yoshida; Joel T Dudley; Irina Budunova
Journal:  Oncotarget       Date:  2016-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.